Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
iTeos Therapeutics, Inc. (ITOS) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
02/03/2023 8-K Quarterly results
01/09/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "4 1 0 1 1 K"
06/13/2022 8-K Quarterly results
01/11/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Targeted Immunotherapies to Improve the Lives of People with Cancer January 2022 Nasdaq: ITOS"
08/10/2021 8-K Quarterly results
07/28/2021 8-K Other Events
06/16/2021 8-K Quarterly results
06/14/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
05/03/2021 8-K Quarterly results
04/12/2021 8-K Quarterly results
03/24/2021 8-K Quarterly results
03/22/2021 8-K Quarterly results
01/11/2021 8-K Quarterly results
11/12/2020 8-K Quarterly results
Docs: "Enrollment continues in Phase 1/2a clinical trial in adult patients with advanced solid tumors: The multi-arm Phase 1/2a clinical trial of EOS-850 trial in adult patients with advanced solid tumors is ongoing. In addition to the single-agent cohort, dosing has also commenced in the second cohort evaluating EOS-850 in combination with pembrolizumab. The COVID-19 pandemic has resulted in the Company experiencing enrollment delays for its third cohort evaluating EOS-850 in combination with chemotherapy. The Company is now opening additional sites in the U.S., France, Spain and South Korea to support continued enrollment and expects to dose the first patient in the chemotherapy cohort by the end of 2020. The Company remains on-track to report initial single-agent and combination data in the fi...",
"iTeos Appoints Matthew Roden, Ph.D. to Board of Directors",
"A2AR 0.7 12 222 17 A1R 192 39 185 61 A2BR 575"
09/01/2020 8-K Quarterly results
07/28/2020 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy